• Professional healthcare
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    ‌
    • Consumer productsConsumer products
      • Home
      • Support
      • Product registration
      • My Philips
    • Healthcare professionalsHealthcare professionals
      • Home
      • Products
      • Services
      • Specialties
      • Solutions
    • Other business solutionsOther business solutions
      • Lighting
      • Automotive
      • Dictation Solutions
      • More
      • Hearing solutions
      • Display solutions
    • About usAbout us
      • Home
      • News
      • Investor Relations
      • Careers
      • More
      • Innovation
      • Environmental, Social and Governance
    • Contact and supportContact and support
      • Customer support
      • Professional healthcare support
      • Company contacts
    • Stay up-to-dateStay up-to-date
    • Select your country / languageGlobal / English
    • Privacy Notice
    • Terms of use
    • Cookie notice
    © Koninklijke Philips N.V., 2004 - 2025. All rights reserved.
    Advanced Physiologic guidance with iFR Co-Registration
    Image-guided therapy

    iFR Co-registration

    Contact salesFind support

    Elevate your physiologic decision-making with iFR Co-registration

    Only Philips iFR Co-registration helps you decide where to treat by mapping the iFR pull back directly onto the angiogram for a new dimension in PCI guidance.  Confident assessment: 38% of stenoses severity classifications changed when using iFR Co-registration compared to using angiography alone [3,4]. Minimize unnecessary stent placement: iFR Co-registration helps identify lesions that will truly benefit from PCI. Tailored intervention: Obtain additional perspective on PCI planning by helping identify strategies for the most physiological gain.

    Demonstrated results

    1. 1 in 4

      patients with successful PCI left the cath lab with residual ischemia

      1 in 4

      patients with successful PCI left the cath lab with residual ischemia

      (defined as iFR <0.90 residual DS <50% in any treated lesion) [1].

    2. 81.6%

      of patients with ischemia, were caused by an inapparent focal stenosis

      81.6%

      of patients with ischemia, were caused by an inapparent focal stenosis

      with residual ischemia, were caused by an untreated angiographically inapparent physiologically focal stenosis (≤ 15 mm) [1].

    3. 79%

      reduction in residual ischemia

      79%

      reduction in residual ischemia

      if all focal lesions had been successfully treated (24% to 5%) [1].

    4. 68%

      relative relative reduction in clinical events

      68%

      relative relative reduction in clinical events

      in clinical events at 1 year follow-up among patients achieving post-PCI iFR ≥ 0.95 (p-value=0.04) [2].

    Virtually plan your PCI and predict results
    Angiography provides a visual picture, but often lacks the detail needed for optimal PCI planning. Only Philips provides advanced physiologic guidance to help you determine not just whether to treat, but also where to treat, ensuring precise, patient-focused care.
    1. Identify the precise locations causing ischemia - each yellow dot signifies a 0.01 drop of iFR
    2. Plan your treatment, before a stent is even placed, with a virtual stent
    3. Determine lesion lengths without need for a pullback device
    4. Predict physiologic gain with iFR Estimate to determine the best treatment strategies
    Advanced physiologic guidance with Philips iFR
    Get advanced physiologic insight
    - Quickly review pressure drops and precise ischemia locations so you can plan your treatment strategy more accurately and easily.
    - Automatically co-register values in seconds onto the angiogram to give you a complete picture
    - Easily assess treatment strategy decisions with virtual stenting to ensure you achieve maximize physiologic gain and reduce guesswork.
    Dr. Allen Jeremias still image from video
    Quickly and easily understand lesion-specific physiology
    Quick iFR Co-registration graphically displays the iFR drop along the angiogram, highlighting which portion of the vessel is ischemic.
    image of Diffuse disease


    World’s first solid core pressure guide wire [7].
    With an all new workhorse design, only Philips OmniWire pressure wire combines confidence in wire performance with proven iFR outcomes and iFR Co-registration, making it easy to benefit from physiology throughout the case [1,5-6].
    View OmniWire
    Image of OmniWire Standard Product
    Footnotes
    1. Jeremias A, et al. Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention: The DEFINE PCI Study. JACC Cardiovasc Interv. 2019;12(20):1991-2001.
    2. Patel M., et al. 1-Year outcomes of blinded physiological assessment of residual ischemia after successful PCI. JACC Cardiol Interv. 2022;15(1):52-61.
    3. Joseph T, Foley M, Al-Lamee R. Physiology and Intravascular Imaging Coregistration—Best of all Worlds? Intervent Cardiol Clin 2023;12:71–82.
    4. Matsuo A, Kasahara T, Ariyoshi M, et al. Utility of angiography–physiology coregistration maps during percutaneous coronary intervention in clinical practice. Cardiovasc Interv Ther 2021;36(2):208–18.
    5. Davies JE, et al., Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017 May 11;376(19):1824-1834.
    6. Gotberg M, et al., iFR-SWEDEHEART Investigators. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017 May 11;376(19):1813-1823.
    7. Data on file D000410086_A, D000485394_A
    Disclaimer
    Always read the label and follow the directions for use.​
    Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.​ Products subject to country availability. Please contact your local sales representative.​
    ©2025 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners. Philips reserves the right to change product specifications without prior notification.